Lichen International Ltd has filed a prospectus supplement to announce a significant offering of 17.5 million units, each consisting of one Class A ordinary share and one ordinary warrant. This offering aims to raise approximately $3.5 million, which the company intends to use to strengthen its financial position amid ongoing regulatory challenges.

The announcement comes at a time when the management consulting services industry is facing increasing scrutiny and evolving regulations. Lichen International, which operates primarily through its subsidiaries in China, is navigating a complex landscape that includes recent regulatory changes affecting foreign investments and capital raising.

Background

Lichen International Ltd, a Cayman Islands exempted company, is classified under the SIC code 8742, which pertains to management consulting services. The company trades on the Nasdaq under the ticker symbol LICN. As of November 10, 2026, Lichen International filed a Form 424B5 to register the offering of these securities, which is part of its ongoing efforts to enhance its capital structure.

What the Filing Says

The filing outlines that the offering consists of 17,500,000 units at a price of $0.20 per unit, which includes one Class A ordinary share or one pre-funded warrant in lieu thereof, along with one ordinary warrant. The total gross proceeds from the offering are estimated to be around $3.5 million, assuming all units are sold and exercised.

Impact

This offering may affect various stakeholders, including investors looking for opportunities in the management consulting sector. The funds raised are expected to provide Lichen International with additional liquidity to navigate the current market conditions. Additionally, competitors in the management consulting services industry may need to reassess their funding strategies in light of Lichen's proactive approach to capital raising.

What's Next

The filing does not specify what happens next regarding the use of proceeds or any subsequent filings related to this offering. However, Lichen International has indicated that it will comply with regulatory requirements as it proceeds with the offering.

Source: SEC Accession Number 0001185185-26-005284